Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ian C Taylor

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Canadian Family Physician Medecin De Famille Canadien|January 23, 2015
We stand by our conclusionMichael R Kolber, Adrienne J Lindblad, Ian C Taylor
Canadian Family Physician Medecin De Famille Canadien|September 14, 2014
Fracture healing and NSAIDsIan C Taylor, Adrienne J Lindblad, Michael R Kolber
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 31, 2024
Oral Estrogen Receptor PROTAC Vepdegestrant (ARV-471) Is Highly Efficacious as Monotherapy and in Combination with CDK4/6 or PI3K/mTOR Pathway Inhibitors in Preclinical ER+ Breast Cancer ModelsSheryl M Gough, John J Flanagan, Jessica Teh, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Canadian Family Physician Medecin De Famille Canadien|January 23, 2015
We stand by our conclusionMichael R Kolber, Adrienne J Lindblad, Ian C Taylor
Canadian Family Physician Medecin De Famille Canadien|September 14, 2014
Fracture healing and NSAIDsIan C Taylor, Adrienne J Lindblad, Michael R Kolber
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 31, 2024
Oral Estrogen Receptor PROTAC Vepdegestrant (ARV-471) Is Highly Efficacious as Monotherapy and in Combination with CDK4/6 or PI3K/mTOR Pathway Inhibitors in Preclinical ER+ Breast Cancer ModelsSheryl M Gough, John J Flanagan, Jessica Teh, et al.
Pageof 1